# Hetero Drugs Ltd · 66-66 · INDIA — FDA import alert red lists: firms subject to detention without physical examination For Hetero Drugs Ltd · 66-66 · INDIA, import alert is 66-66; import alert name is "APIs That Appear To Be Misbranded Under 502(f)(1) Because They Do Not Meet The Requirements For The Labeling Exemptions In 21 CFR 201.122"; country is INDIA; product is Doxazosin Mesylate; product code is 62 O - S 27 Doxazosin Mesylate (Anti-Hypertensive - Part II), Active Pharm Ingred/Chems for Further Manuf; date published is 09/30/2009; address is 7 1 Hetero House # 8 - 3 - 166 , Hyderabad, Telangana INDIA, verified against its source on 2026-09-16. - **Firm:** Hetero Drugs Ltd _(verified: appears in the quote below)_ - **Import alert:** 66-66 - **Import alert name:** "APIs That Appear To Be Misbranded Under 502(f)(1) Because They Do Not Meet The Requirements For The Labeling Exemptions In 21 CFR 201.122" - **Country:** INDIA _(verified: appears in the quote below)_ - **Address:** 7 1 Hetero House # 8 - 3 - 166 , Hyderabad, Telangana INDIA _(verified: appears in the quote below)_ - **Date published:** 09/30/2009 _(verified: appears in the quote below)_ - **Product code:** 62 O - S 27 Doxazosin Mesylate (Anti-Hypertensive - Part II), Active Pharm Ingred/Chems for Further Manuf _(verified: appears in the quote below)_ - **Product:** Doxazosin Mesylate _(verified: appears in the quote below)_ - **FDA notes:** 10/3/2000 _(verified: appears in the quote below)_ ## What the source says > Hetero Drugs Ltd Date Published : 09/30/2009 7 1 Hetero House # 8 - 3 - 166 , Hyderabad, Telangana INDIA 62 O - S 27 Doxazosin Mesylate (Anti-Hypertensive - Part II), Active Pharm Ingred/Chems for Further Manuf Date Published: 03/29/2019 Desc: Doxazosin Mesylate Notes: 10/3/2000 ## Source - https://www.accessdata.fda.gov/cms_ia/importalert_202.html Last verified: 2026-09-16. Review by: 2026-11-15. Part of [FDA import alert red lists: firms subject to detention without physical examination](https://referencesource.org/fda-import-alert-red-list/).